AzTrials
AzTrials

Lumbar Disc Herniation With RadiculopathyNCT07263737

Pulsed Electromagnetic Field Therapy for Neuropathic Pain in Lumbar Disc Herniation

A study testing Pulsed electromagnetic field (PEMF) in people with Lumbar Disc Herniation With Radiculopathy, run by Haydarpasa Numune Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled study evaluated whether adding pulsed electromagnetic field (PEMF) therapy to conventional physical therapy provides additional benefits for neuropathic pain and disability in patients with lumbar disc herniation (LDH). Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Pulsed electromagnetic field (PEMF)
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
46 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Oct 2022to 15 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • • Radicular pain and neuropathic symptoms lasting longer than 3 months
  • Presence of lumbar disc herniation on lumbar MRI
  • Age between 18 and 75 years
  • Visual Analog Scale (VAS) ≥ 4
  • DN4 ≥ 4
  • At least one positive test among Straight Leg Raise Test (SLRT) and femoral stretch test
  • Patients without cognitive impairment who are able to follow verbal instructions

Who cannot join

  • -• Having undergone an interventional lumbar injection within the last 3 months
  • Receiving physical therapy within the last 3 months
  • Using medical treatment for neuropathic pain within the last 3 months
  • History of lumbar surgery
  • Presence of another neurological disorder that could cause neuropathic symptoms
  • Cauda equina syndrome
Show all 11Show fewer
  • History of malignancy
  • Uncontrolled cardiopulmonary disease
  • Pregnancy
  • Presence of a pacemaker or electronic implant
  • Presence of diabetic neuropathy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Haydarpasa Numune Training and Research Hospital Physical Rehabilitation and Medicine Clinic

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Effectiveness of Pulsed Electromagnetic Field Therapy on Neuropathic Pain and Disability in Patients With Lumbar Disc Herniation: A Randomized, Double-Blind, Placebo-Controlled Trial

This randomized controlled study evaluated whether adding pulsed electromagnetic field (PEMF) therapy to conventional physical therapy provides additional benefits for neuropathic pain and disability in patients with lumbar disc herniation (LDH).

→ This study randomly assigned patients into groups to compare treatments. It examined whether adding pulsed electromagnetic field (PEMF) therapy to standard physical therapy could give extra improvement in nerve-related pain and daily function in people with a slipped disc in the lower back.

Read more

Fifty-two patients with ≥3 months of radicular and neuropathic symptoms were enrolled and randomly assigned to a treatment group (PEMF + conventional therapy) or a control group (sham PEMF + conventional therapy).

→ Fifty-two patients who had leg pain and nerve-related symptoms for at least three months joined the study. They were randomly placed into either a treatment group (which received PEMF plus regular therapy) or a control group (which received a fake PEMF treatment plus regular therapy).

Both groups received transcutaneous electrical nerve stimulation, hot packs, and a lumbar exercise program for 15 sessions.

→ Both groups also received the same standard treatments: electrical nerve stimulation, hot packs, and a lower-back exercise program for 15 sessions.

Clinical outcomes-including Visual Analog Scale (VAS), pressure pain threshold, Modified Schober test, DN4, PainDetect, Oswestry Disability Index (ODI), and SF-36-were assessed at baseline, post-treatment, and one month after treatment.

→ Several health measures were checked before treatment, right after treatment, and again one month later. These included pain level (VAS), how sensitive the area was to pressure, lower-back flexibility, nerve-pain questionnaires (DN4 and PainDetect), disability level (ODI), and overall quality of life (SF-36).

Forty-six patients completed the study. → A total of 46 patients finished the study.

Both groups showed significant improvements in VAS scores, neuropathic pain questionnaires (DN4, PainDetect), ODI, and several SF-36 subscales (physical functioning, role-physical, and pain), with additional improvements in emotional role and social functioning observed only in the PEMF group.

→ Both groups improved in many areas: pain levels, nerve-pain scores, disability, and some parts of quality of life (such as physical functioning, daily roles, and pain). Only the PEMF group showed extra improvement in emotional well-being and social activities.

However, none of the between-group comparisons demonstrated significant differences.

  • However, when the two groups were compared to each other, there were no meaningful differences.

No meaningful changes were found in lumbar flexibility or pressure pain thresholds in either group.

→ Neither group showed important changes in lower-back flexibility or in how much pressure they could tolerate on painful areas.

In conclusion, adding PEMF therapy to conventional physical therapy did not provide additional benefit for neuropathic symptoms, radicular pain, disability, lumbar flexibility, pressure pain threshold, or quality of life in patients with LDH-related neuropathic pain.

→ In summary, adding PEMF therapy to regular physical therapy did not give extra benefits for nerve pain, leg pain, disability, back flexibility, sensitivity to pressure, or quality of life in people with nerve-related pain caused by a slipped disc.

Being tested
Pulsed electromagnetic field (PEMF), Sham PEMF
Keywords
pulsed electromagnetic field, neuropathic pain, lumbar disck herniation
Medical subject headings
Neuralgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulsed electromagnetic field (PEMF)Device

    In our study, the device used for PEMA application was the BTL-4000 Smart. The PEMA waves applied to the treatment group were elongated square-wave signals with a frequency of 55.55 Hz and a magnetic flux density of 30 mT. A 60-cm solenoid applicator of the device was used. With this applicator, a 30-minute treatment was delivered to cover the lumbar region.

  • Sham PEMFDevice

    Sham application with the same device

Study groups in NCT07263737
Study groupRoleWhat they receive
Pulsed electromagnetic field (PEMF) and physical therapyExperimentalThe physical therapy protocol was arranged as follows: 20 minutes of hot pack application to the lumbar region, 10 minutes of rest, 20 minutes of conventional transcutaneus electrical nerve stimulation (TENS) applied to the lumbar region and along the radicular pain pathway, followed by another 10 minutes of rest, and finally 30 minutes of magnetic field therapy . One session lasted a total of 90 minutes. On the first day, patients were thoroughly instructed in a home exercise program that included lumbar isometric strengthening, pelvic tilt exercises, hamstring stretching, and core stabilization exercises. They were asked to perform each exercise twice daily with ten repetitions throughout the physical therapy program. Patients received one session per day, five days per week, for a total of 15 sessions.
Receives: Device: Pulsed electromagnetic field (PEMF)
Sham Pulsed electromagnetic field (PEMF) and physical therapySham comparatorThe physical therapy protocol was arranged as follows: 20 minutes of hot pack application to the lumbar region, 10 minutes of rest, 20 minutes of conventional transcutaneus electrical nerve stimulation (TENS) applied to the lumbar region and along the radicular pain pathway, followed by another 10 minutes of rest, and finally 30 minutes of sham magnetic field therapy . One session lasted a total of 90 minutes. On the first day, patients were thoroughly instructed in a home exercise program that included lumbar isometric strengthening, pelvic tilt exercises, hamstring stretching, and core stabilization exercises. They were asked to perform each exercise twice daily with ten repetitions throughout the physical therapy program. Patients received one session per day, five days per week, for a total of 15 sessions.
Receives: Device: Sham PEMF

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VAS

    Visual Analog Scale (VAS): VAS is the most frequently used parameter for measuring pain intensity in low back pain studies. It is a self-reported scale that typically consists of a 10-cm horizontal or vertical line with two verbal descriptors placed at each end to indicate the extremes of pain. Patients are asked to mark the point that best represents their pain. The VAS score is obtained by measuring the distance in centimeters from the starting point to the patient's mark. In our study, VAS was used to assess the pain experienced by patients in the low back and leg regions during the previous week. VAS was evaluated in three different conditions: at rest, during movement, and at night.

    Measured: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

  2. PPT

    Pressure Pain Threshold (PPT) Measurements with an Algometer:

    An algometer is a pressure-measuring device with a 1-cm rounded tip. The sensation of pressure and pain occurs when polymodal nociceptive nerve endings in superficial and deep tissues are stimulated. Algometers are used in clinical studies to measure the pressure pain threshold.

    After the measurement points are identified, the rounded tip of the device is placed perpendicular to the surface of the body being examined. Pressure is increased continuously at a rate of approximately 1 kg per second. Patients are instructed to indicate the moment they first feel any pain or discomfort. As soon as they report this sensation, the pressure is stopped and the pressure pain threshold value is read from the device .

    In our study, PPTmeasurements obtained with an algometer were used to evaluate the patients' pain sensitivity. The Jtech Commander Algometer was used as the device.

    Measured: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

Secondary outcomes (4)
  1. Neuropathic pain

    DN4 and PainDetect Questionnaire (PDQ)

    Measured: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

  2. Physical examination tests

    Straight Leg Raise Test (SLRT), femoral stretch test, and the Modified Schober test

    Measured: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

  3. Disability

    Oswestry Disability Index (ODI)

    Measured: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

  4. Quality of life Short Form-36 (SF-36) questionnaire

    The SF-36 questionnaire was developed by Ware as a general assessment tool intended for use in many diseases, evaluating quality of life through physical and mental health parameters.

    Measured: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Dec 2025
  2. Study start30 Oct 2022
  3. Primary completion15 Jul 2023
  4. Study completion15 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07263737
Sponsor's protocol ID
HNEAH-KAEK 2022/KK/124
Status last verified
Feb 2026
First submitted
23 Nov 2025
Last updated
18 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The study data are available with the researcher and can be provided to the relevant authorities if required.

Questions about this trial

What is this clinical trial studying?

A study testing Pulsed electromagnetic field (PEMF) in people with Lumbar Disc Herniation With Radiculopathy, run by Haydarpasa Numune Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VAS (time frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in